{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:12:06Z","timestamp":1790172726032,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":761,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/pme.12143","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T15:05:40Z","timestamp":1369407940000},"page":"1202-1211","source":"Crossref","is-referenced-by-count":42,"title":["The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis"],"prefix":"10.1093","volume":"14","author":[{"given":"Till","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Roth-Daniek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"2016022620390566000_14.8.1202.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70143-5"},{"key":"2016022620390566000_14.8.1202.2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000282763.29778.59"},{"key":"2016022620390566000_14.8.1202.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.01.006"},{"key":"2016022620390566000_14.8.1202.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.013"},{"key":"2016022620390566000_14.8.1202.5","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.ejpain.2007.03.472","article-title":"Systematic review of the prevalence of neuropathic pain","volume":"11","author":"Mallis Gagnon","year":"2007","journal-title":"Eur J Pain"},{"key":"2016022620390566000_14.8.1202.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.11.008"},{"key":"2016022620390566000_14.8.1202.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.007"},{"key":"2016022620390566000_14.8.1202.8","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.73.8.726"},{"key":"2016022620390566000_14.8.1202.9","doi-asserted-by":"publisher","DOI":"10.2174\/1874467210801030255"},{"key":"2016022620390566000_14.8.1202.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.09.019"},{"key":"2016022620390566000_14.8.1202.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.07.017"},{"key":"2016022620390566000_14.8.1202.12","doi-asserted-by":"publisher","DOI":"10.2165\/11206050-000000000-00000"},{"key":"2016022620390566000_14.8.1202.13","doi-asserted-by":"crossref","unstructured":"Bley KR . TRPV1 agonist approaches for pain management. In: Gomtsyan A Faltynek CR , eds. vanilloid Receptor TRPV1 in Drug Discovery. Hoboken, NJ: John Wiley & Sons, Inc; 2010:325\u2013347.","DOI":"10.1002\/9780470588284.ch13"},{"key":"2016022620390566000_14.8.1202.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70228-X"},{"key":"2016022620390566000_14.8.1202.15","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000314647.35825.9c"},{"key":"2016022620390566000_14.8.1202.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.01004.x"},{"key":"2016022620390566000_14.8.1202.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2009.00793.x"},{"key":"2016022620390566000_14.8.1202.18","unstructured":"Simpson D Brown S Chang S Jermano J , the C107 Study Team. Long-term intermittent treatment with high-concentration capsaicin dermal patch (CDP, NGX-4010) for painful HIV-associated distal sensory polyneuropathy (DSP). XVI International AIDS Conference; August 13\u221218, 2006, Toronto, Canada (Abstract Poster No. THPE0073)."},{"key":"2016022620390566000_14.8.1202.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.11.316"},{"key":"2016022620390566000_14.8.1202.20","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2011.20.15.926"},{"key":"2016022620390566000_14.8.1202.21","unstructured":"Astellas Pharma Europe Ltd. Summary of product characteristics: Qutenza 179 mg cutaneous patch. 2013. European Commission: Community register of medicinal products for human use. Available at: http:\/\/ec.europa.eu\/health\/documents\/community-register\/2013\/20130311125355\/anx_125355_en.pdf (accessed April 4, 2013)."},{"key":"2016022620390566000_14.8.1202.22","unstructured":"AstraZeneca LP. EMLA\u00ae: CREAM (lidocaine 2.5% and prilocaine 2.5%). 2005. AstraZeneca LP, Wilmington, DE, USA. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/019941s018lbl.pdf (accessed February 25, 2013)."},{"key":"2016022620390566000_14.8.1202.23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2016022620390566000_14.8.1202.24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-92"},{"key":"2016022620390566000_14.8.1202.25","doi-asserted-by":"crossref","unstructured":"Webster LR Malan TP Tuchman MM Duration of treatment response to NGX-4010 (Qutenza\u00ae), a high-concentration capsaicin patch, in patients with postherpetic neuralgia. 29th Annual Scientific Meeting of the American Pain Society, May 6\u22128, 2010, Baltimore, Maryland, USA (Abstract).","DOI":"10.1016\/S1754-3207(10)70510-1"},{"key":"2016022620390566000_14.8.1202.26","unstructured":"Irving G Backonja MM Lu B Quality of life measures in post-herpetic neuralgia patients treated with NGX-4010: Results of integrated analyses. 13th World Congress on Pain, August 29\u2212September 2, 2010, Montr\u00e9al, Qu\u00e9bec, Canada (Abstract PT 102)."},{"key":"2016022620390566000_14.8.1202.27","unstructured":"Panarites CJ Dworkin RH Pham SV Malone D Armstrong E . Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on healthcare costs. 61st Annual Meeting of the American Academy of Neurology (AAN), April 25\u2212May 2, 2009, Seattle, Washington, USA (Abstract Poster No. P05.042)."}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/14\/8\/1202\/5235046\/14-8-1202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T01:00:07Z","timestamp":1715389207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/pme.12143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,1]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1111\/pme.12143"],"URL":"https:\/\/doi.org\/10.1111\/pme.12143","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}